Africa’s first COVID-19 vaccine plant, Aspen Pharmacare located in South Africa, is on the verge of closing down following low patronage as orders have continued to drop drastically.
According to BBC Africa News, there is growing pressure on countries across Africa to buy Covid-19 vaccines from Aspen, the first company to produce the vaccines on the continent.
However, the company has issued a warning that it may have to stop producing Covid vaccines as countries have failed to place orders in recent months.
The deal which allowed Aspen to produce and sell Aspenovax was seen as an important step in helping to improve equal access to Covid vaccines.
But the head of the Africa’s leading public health body, the Africa CDC, is however, urging Covax, the international scheme which many African states rely on for Covid vaccines, to buy from the plant so as to keep it from going under, while
Aspen’s group senior executive, Stavros Nicolau, said Covax had not bought a single vaccine made in Africa.
Meanwhile, South Africa’s President Cyril Ramaphosa, says he was working with counterparts in four African countries to try and save Aspen’s Covid vaccine production line.
But the head of the Africa CDC says that choosing to buy from Africa “is a political decision.”
In a statement defending its position, Covax said though it was “committed to diversifying global supply specially in Africa” but it argues that lack of demand means it is not in a position to buy large quantities of vaccines.